Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Clinical and Translational Science|January 19, 2022
Single-dose of LC51-0255, a selective S1P1 receptor modulator, showed dose-dependent and reversible reduction of absolute lymphocyte count in humansSang Won Lee, Inyoung Hwang, Jaeseong Oh, et al.Frontiers in Pharmacology|September 8, 2022
Dose-dependent reduction of lymphocyte count and heart rate after multiple administration of LC51-0255, a novel sphingosine-1-phosphate receptor 1 modulator, in healthy subjectsInyoung Hwang, Sang Won Lee, Jaeseong Oh, et al.Journal of Ethnopharmacology|October 24, 2025
Pharmacokinetic and pharmacodynamic herb-drug interaction of aspirin with Ijintang (Er Chen Tang) or Cheongsanggyeontongtang (Qing Shang Juan Tong Tang): An exploratory study in healthy adultsInyoung Hwang, Ju Hee Kim, Jungbin Song, et al.Translational and Clinical Pharmacology|February 26, 2020
Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjectsEunsol Yang, Soyoung Lee, Heechan Lee, et al.Life (Basel, Switzerland)|May 25, 2024
Comparison of the Effects of Pilates and Yoga Exercise on the Dynamic Balancing Ability and Functional Movement of FencersSo-Jung Lim, Hyun-Jin Kim, Yong-Soo Kim, et al.Clinical and Translational Science|December 14, 2022
Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizersWoo Kyung Chung, Inyoung Hwang, Byungwook Kim, et al.Translational and Clinical Pharmacology|April 11, 2020
Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjectsXuanyou Jin, Eunwoo Kim, Ki Young Huh, et al.Translational and Clinical Pharmacology|February 15, 2020
Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjectsInyoung Hwang, Sang-In Park, SeungHwan Lee, et al.Clinical Therapeutics|September 27, 2020
Pharmacokinetics and Tolerability of LC28-0126, a Novel Necrosis Inhibitor, After Multiple Ascending Doses: A Phase I Randomized, Double-blind, Placebo-controlled Study in Healthy Male SubjectsEunwoo Kim, Inyoung Hwang, SeungHwan Lee, et al.Clinical and Translational Science|June 21, 2022
The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjectsSejung Hwang, Soyoung Lee, Eunwoo Kim, et al.Pageof 3